Business · 24/08/2026
Government Owned Invention Available for License: T Cell Receptors Targeting HPV 6 or HPV 11
The National Cancer Institute is seeking partners to co-develop or license a collection of T cell receptors that target specific antigens from human papillomavirus types 6 and 11, with the goal of developing new cancer treatments.
Original source language: Federal Register — Health and Human ServicesOpen original release →